Ignite Creation Date:
2024-05-06 @ 7:06 PM
Last Modification Date:
2024-10-26 @ 3:00 PM
Study NCT ID:
NCT05892185
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-06-07
First Post:
2023-05-23
Brief Title:
Evaluate the Efficacy and Safety of Glaucoma Implant in Primary Open Angle Glaucoma
Sponsor:
Mingche Biotechnology CO LTD
Organization:
Mingche Biotechnology CO LTD
Study Overview
Official Title:
A Randomized Single-blind Parallel Group Study to Evaluate the Efficacy and Safety of Glaucoma Implant in Primary Open Angle Glaucoma
Status:
NOT_YET_RECRUITING
Status Verified Date:
2023-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The objective of this study is to evaluate the efficacy and safety of glaucoma device in the treatment of primary open-angle glaucoma
Detailed Description:
A prospective randomized single-blind positive control design was used to study primary open-angle glaucoma Eligible subjects were screened and randomly assigned to the experimental group and the control group
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None